Hereditary Cancer in Clinical Practice | Most Viewed

Submit a manuscript Register Contact us Follow
BioMed Central Support

Explore journal

Advertisement

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 504 Accesses	Research Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models Karen A Kopciuk, Yun-Hee Choi, Elena Parkhomenko, Patrick Parfrey, John McLaughlin, Jane Green, Laurent Briollais Hereditary Cancer in Clinical Practice 2009, 7:16 (28 October 2009) Abstract \| Full text \| PDF \| PubMed
	2. 386 Accesses	Review Hamartomatous polyposis syndromes Zoran Stojcev, Pawel Borun, Jacek Hermann, Piotr Krokowicz, Wojciech Cichy, Lukasz Kubaszewski, Tomasz Banasiewicz, Andrzej Plawski Hereditary Cancer in Clinical Practice 2013, 11:4 (1 June 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	3. 308 Accesses	Letter to the Editor Carcinogenesis of PIK3CA Sidra German, Hafiz Muhammad Aslam, Shafaq Saleem, Aisha Raees, Tooba Anum, Arsalan Ahmad Alvi, Abdul Haseeb Hereditary Cancer in Clinical Practice 2013, 11:5 (15 June 2013) Abstract \| Provisional PDF
	4. 268 Accesses	Research Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk Lisa A Howell, Pamela S Sinicrope, Tabetha A Brockman, Christi A Patten, Paul A Decker, Shawna L Ehlers, Ashley Nadeau, Kari G Rabe, Carmen Radecki Breitkopf, Gloria M Petersen Hereditary Cancer in Clinical Practice 2013, 11:3 (31 May 2013) Abstract \| Provisional PDF \| PubMed
	5. 247 Accesses	Research MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer Bente A Talseth-Palmer, Mary McPhillips, Claire Groombridge, Allan Spigelman, Rodney J Scott Hereditary Cancer in Clinical Practice 2010, 8:5 (21 May 2010) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary The Australian authors identified 26 different MSH6 and 4 different PMS2 mutations in 35 Lynch syndrome families studied. For MSH6 mutation carriers, the estimated cumulative risk of CRC at age 70 years was 61% (similar in males and females) and 65% for endometrial cancer. The risk of developing CRC was found to be different between males and females at age 50 years: 34% for males and 21% for females.
	6. 247 Accesses	Short report Encyclopaedia of tumour-associated familial disorders. Part I: from AIMAH to CHIME syndrome Rolf H Sijmons Hereditary Cancer in Clinical Practice 2008, 6:22-57 (15 March 2008) Abstract \| Full text \| PDF \| PubMed
	7. 201 Accesses	Research Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management Dewkoemar Ramsoekh, Anja Wagner, Monique E van Leerdam, Dennis Dooijes, Carli MJ Tops, Ewout W Steyerberg, Ernst J Kuipers Hereditary Cancer in Clinical Practice 2009, 7:17 (23 December 2009) Abstract \| Full text \| PDF \| PubMed
	8. 187 Accesses	Review Systemic treatment for hereditary cancers: a 2012 update Evgeny N Imyanitov, Tomasz Byrski Hereditary Cancer in Clinical Practice 2013, 11:2 (1 April 2013) Abstract \| Full text \| PDF \| PubMed
	9. 185 Accesses	Review Familial gastric cancer: detection of a hereditary cause helps to understand its etiology Ingrid P Vogelaar, Rachel S van der Post, Tanya M Bisseling, J Han JM van Krieken, Marjolijn JL Ligtenberg, Nicoline Hoogerbrugge Hereditary Cancer in Clinical Practice 2012, 10:18 (12 December 2012) Abstract \| Full text \| PDF \| PubMed
	10. 182 Accesses	Research A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome Ani Kardashian, Julia Fehniger, Jennifer Creasman, Eleanor Cheung, Mary Beattie Hereditary Cancer in Clinical Practice 2012, 10:4 (12 April 2012) Abstract \| Full text \| PDF \| PubMed
	11. 180 Accesses	Case report Familial Multiple Myeloma: Report on Two Families and Discussion of Screening Options Erica H Gerkes, Mirjam M de Jong, Rolf H Sijmons, Edo Vellenga Hereditary Cancer in Clinical Practice 2007, 5:72-78 (15 June 2007) Abstract \| Full text \| PDF \| PubMed
	12. 173 Accesses	Case report Unusual presentation of Lynch Syndrome Veronica PCC Yu, Marco Novelli, Stewart J Payne, Sam Fisher, Rebecca A Barnetson, Ian M Frayling, Ann Barrett, David Goudie, Audrey Ardern-Jones, Ros Eeles, Susan Shanley Hereditary Cancer in Clinical Practice 2009, 7:12 (3 June 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	13. 165 Accesses	Research Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations Katarina Bartuma, Mef Nilbert, Christina Carlsson Hereditary Cancer in Clinical Practice 2012, 10:6 (25 May 2012) Abstract \| Full text \| PDF \| PubMed
	14. 166 Accesses	Research Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon Nadine Jalkh, Jinane Nassar-Slaba, Eliane Chouery, Nabiha Salem, Nancy Uhrchammer, Lisa Golmard, Domique Stoppa-Lyonnet, Yves-Jean Bignon, André Mégarbané Hereditary Cancer in Clinical Practice 2012, 10:7 (19 June 2012) Abstract \| Full text \| PDF \| PubMed
	15. 159 Accesses	Research Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study LaCreis R Kidd, Dominique Z Jones, Erica N Rogers, Nayla C Kidd, Sydney Beache, James E Rudd, Camille Ragin, Maria Jackson, Norma McFarlane-Anderson, Marshall Tulloch-Reid, Seian Morrison, Guy N Brock, Shirish S Barve, Kevin S Kimbro Hereditary Cancer in Clinical Practice 2012, 10:16 (20 November 2012) Abstract \| Full text \| PDF \| PubMed
	16. 148 Accesses	Review Familial paragangliomas CJM Lips, EGWM Lentjes, JWM Höppener, RB Luijt, FL Moll Hereditary Cancer in Clinical Practice 2006, 4:169-176 (15 October 2006) Abstract \| Full text \| PDF \| PubMed
	17. 148 Accesses	Review DNA and RNA analyses in detection of genetic predisposition to cancer Grzegorz Kurzawski, Dagmara Dymerska, Pablo Serrano-Fernández, Joanna Trubicka, Bartłomiej Masojć, Anna Jakubowska, Rodney J Scott Hereditary Cancer in Clinical Practice 2012, 10:17 (4 December 2012) Abstract \| Full text \| PDF \| PubMed
	18. 138 Accesses	Research Molecular study of the perforin gene in familial hematological malignancies Rim El Abed, Violaine Bourdon, Ilia Voskoboinik, Halima Omri, Yosra Youssef, Mohamed Laatiri, Laetitia Huiart, François Eisinger, Laetitia Rabayrol, Marc Frenay, Paul Gesta, Liliane Demange, Hélène Dreyfus, Valérie Bonadona, Catherine Dugast, Hélène Zattara, Laurence Faivre, Monia Zaier, Saloua Jemni, Testsuro Noguchi, Hagay Sobol, Zohra Soua Hereditary Cancer in Clinical Practice 2011, 9:9 (21 September 2011) Abstract \| Full text \| PDF \| PubMed
	19. 137 Accesses	Research Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum Rein P Stulp, Johanna C Herkert, Arend Karrenbeld, Bart Mol, Yvonne J Vos, Rolf H Sijmons Hereditary Cancer in Clinical Practice 2008, 6:15-21 (15 March 2008) Abstract \| Full text \| PDF \| PubMed
	20. 138 Accesses	Case report Rare vertebral metastasis in a case of Hereditary Paraganglioma Manuel Eduardo da Silva, Manuel João Queiroz de Fariados Santos Carvalho, António Pedro Rodrigues, Nuno Silva Neves, António Gonçalves, Rui Alexandre Pinto, Davide Carvalho Hereditary Cancer in Clinical Practice 2012, 10:12 (21 September 2012) Abstract \| Full text \| PDF \| PubMed
	21. 136 Accesses	Review Drug therapy for hereditary cancers Evgeny N Imyanitov, Vladimir M Moiseyenko Hereditary Cancer in Clinical Practice 2011, 9:5 (6 August 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	22. 133 Accesses	Case report Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome Giovanni Ponti, Aldo Tomasi, Lorenza Pastorino, Cristel Ruini, Carmelo Guarneri, Victor Mandel, Stefania Seidenari, Giovanni Pellacani Hereditary Cancer in Clinical Practice 2012, 10:15 (29 October 2012) Abstract \| Full text \| PDF \| PubMed
	23. 133 Accesses	Research Factors Influencing Cancer Risk Perception in High Risk Populations: A Systematic Review Jon C Tilburt, Katherine M James, Pamela S Sinicrope, David T Eton, Brian A Costello, Jantey Carey, Melanie A Lane, Shawna L Ehlers, Patricia J Erwin, Katherine E Nowakowski, Mohammad H Murad Hereditary Cancer in Clinical Practice 2011, 9:2 (19 May 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Patients at higher than average risk of heritable cancer may process risk information differently than the general population. However, little is known about clinical, demographic, or psychosocial predictors that may impact risk perception in these groups. The authors from the Mayo clinic searched literature databases for published research on these topics. Family history of cancer, previous prophylactic tests and treatments, and younger age have been shown to be associated with cancer risk perception. In addition, beliefs about the preventability and severity of cancer, personality factors such as "monitoring" personality, the ability to process numerical information, as well as distress/worry also were associated with cancer risk perception. Few studies addressed non-breast cancer or risk perception in specific demographic groups (e.g. elderly or minority groups) and few employed theory-driven analytic strategies to decipher interrelationships of factors. Clearly, there is need for additional studies.
	24. 128 Accesses	Research BRAF mutations in thyroid tumors from an ethnically diverse group Hans-Juergen Schulten, Sherine Salama, Zuhoor Al-Mansouri, Reem Alotibi, Khalid Al-Ghamdi, Osman Al-Hamour, Hassan Sayadi, Hosam Al-Aradati, Adel Al-Johari, Etimad Huwait, Mamdooh Gari, Mohammed Al-Qahtani, Jaudah Al-Maghrabi Hereditary Cancer in Clinical Practice 2012, 10:10 (27 August 2012) Abstract \| Full text \| PDF \| PubMed
	25. 124 Accesses	Research Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients Douglas L Riegert-Johnson, Ferga C Gleeson, Maegan Roberts, Krysta Tholen, Lauren Youngborg, Melvin Bullock, Lisa A Boardman Hereditary Cancer in Clinical Practice 2010, 8:6 (17 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary In this study from the Mayo clinic, a total of 211 Cowden syndrome patients were included. The cumulative lifetime risks were 89% for any cancer diagnosis, breast cancer [female] 81%, Lhermitte-Duclos disease 32%, thyroid cancer 21%, endometrial cancer 19%, and renal cancer 15%. A previously unreported increased lifetime risk for colorectal cancer was identified (16%, 95% CI = 8%-24%). Male CS patients had fewer cancers diagnosed than female patients and often had cancers not classically associated with CS. Seven percent of breast and thyroid cancers occurred in patients who were younger than the recommended age to commence radiographic cancer screening!